- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Congress Must Act for Cannabis Patients! Pass Medical Cannabis Legislation NOW! Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Pages tagged "Petition"
Posted on Blogs by · October 05, 2011 3:34 AM
Patient advocates in Montana, including members of Americans for Safe Access, were successful this week in gathering enough signatures to overturn SB423, an extremely restrictive medical cannabis bill that took away many of the patients’ rights enshrined in Initiative 148, passed by 62 percent of voters in 2004. Since its passage last session, SB423 has threatened to reduce the number of patients who can qualify for protection under the state law by 90 percent. It also eliminated virtually all access to localized distribution, forcing thousands of patients into the illicit market.
Although a lawsuit was partially successful in rolling back some of the restrictions imposed by SB423, it was unable to nullify the entire bill. Not wanting to rely completely on the courts, patient advocates began a signature drive to put the legislation on the ballot.
It is now up to the voters to reject the onerous provisions of SB423 in its entirety in order to pave the way for more sensible regulation and reform. Local activist and medical cannabis attorney, Chris Lindsey, commented on the progress made by the reformation committee stating that:
We had a voter-approved law that was repealed by our state's politicians. When they were unable to come up with a complete ban, they cooked up a law that punishes people who wanted to participate in the medical marijuana program. The current law does not protect patents and those who provide to them. What we need is smart regulation, not a punitive law that works against the rights of Montana citizens.
Lindsey speaks on behalf of thousands of patients whose access has been seriously compromised with the passage of SB423, and who agree that smart regulation is needed to resurrect safe and legal access to their medication.
Placing this issue on the ballot is a great step in the right direction, and will hopefully restore the rights of Montana patients established under Initiative 148. However, the work is far from over. Our opposition has made it clear that the scope of Initiative 148 is too broad, and now it is up to the patient community in Montana to educate the greater public on why SB423 is not the “regulatory” answer.